Business Context and Reporting Period
This Form 8-K Current Report for Netcapital Inc. covers events occurring on January 3, 2023. The filing details significant corporate governance changes, including the resignation of the Chief Executive Officer (CEO), the appointment of a new CEO, the adoption of a new equity incentive plan, and the granting of stock options to key personnel.
Key Financial Metrics and Compensation
The filing does not report revenue, profit, cash flow, or debt metrics. Financial data is limited to compensation terms and equity grant details:
- New CEO Base Salary: $300,000 annually.
- CEO Performance Bonus: 0.005% of gross revenue paid in cash annually, contingent on the Company reporting positive earnings after the bonus is paid.
- Equity Grant Exercise Price: $1.43 per share for all options granted on January 3, 2023.
- Equity Plan Size: The 2023 Omnibus Equity Incentive Plan authorizes 2,000,000 shares initially, representing approximately 34.1% of Common Stock outstanding as of January 3, 2023.
Material Changes Versus Prior Period
The filing reports the following material changes effective January 3, 2023:
- Executive Leadership Transition: Cecilia Lenk resigned as CEO. She will remain a director and serve as CEO of the wholly-owned subsidiary, Netcapital Advisors Inc. Martin Kay was appointed as the new CEO.
- Equity Plan Adoption: The Board approved the 2023 Omnibus Equity Incentive Plan, pending stockholder approval. This plan allows for annual increases in authorized shares up to the lesser of 5% of outstanding shares or 300,000 shares.
- Unregistered Sales of Equity: The Company granted non-qualified stock options to the new CEO and other officers under the new plan.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking financial guidance, revenue outlook, or management commentary regarding market conditions. The primary focus is on the structural changes to executive compensation and equity incentives. Key contingencies include:
- Stockholder Approval: The 2023 Plan and the specific option grants described are subject to approval by the Company's stockholders.
- Employment Terms: The new CEO's employment agreement has a three-year term and includes provisions for termination for cause, disability, or "good reason," as well as a six-month non-competition clause.
Important Facts for Investor Verification
- Verify the outcome of the stockholder vote required to approve the 2023 Omnibus Equity Incentive Plan and the associated option grants.
- Confirm the vesting schedule for the 1,000,000 options granted to Martin Kay and the 600,000 options granted to other officers (48 equal monthly installments).
- Monitor the Company's ability to report positive earnings, as this is a condition for the new CEO's annual revenue-based bonus.
- Note that the initial 2,000,000 shares authorized under the new plan represent a significant portion (34.1%) of the outstanding common stock, which may impact dilution.